Section of Oncology
Two factors play a small but nevertheless important part in the overall pattern of deaths attributed to bladder tumours. The first is the inaccuracy of cause-of-death entries on some death certificates of bladder cancer patients, and the second is a probable excess of cases of the disease among patients with neurogenic bladder conditions. Accuracy of Death Certificates National death rates are based on official statistics of numbers of deaths from different diseases, and these in turn are derived from the causes of death entered on certificates. Various studies have been made of the accuracy of death certificates (e.g. Kuller et al. 1967 ), but none previously which has concentrated on bladder cancer. A study has been made of the certified causes of death of a series of 809 patients who were treated for bladder cancer at the Royal Marsden Hospital and who subsequently died after widely varying intervals (Davies & Wallace, in preparation). Table 1 shows where or by whom the deaths were certified. It is thought that the death certificates may be fairly representative of those for patients who have attended a centre specializing in the treatment of this disease.
For official statistics death is assigned to the disease entered as the 'underlying cause' in part I of the cause of death. The underlying cause was given as bladder cancer on 609 of the certificates, and as some other cause on the other 200although bladder cancer was often mentioned on these as a 'contributory cause' under part 2. Some typical wordings giving bladder cancer as the underlying cause are: la Terminal bronchopneumonia b Carcinoma of the bladder; la Pulmonary embolus b Operation ureteric transplant c Carcinoma of the bladder.
The 609 cases with death assigned to bladder cancer were examined carefully, and a judgement was made as to whether this assignment was correct. The judgement was based on information in hospital case notes and post-mortem reports, and on personal recollection of the patients. Of these assignments 589 were judged correct, 15 doubtful, and 5 incorrect in that death appeared definitely attributable to some other disease.
The 200 cases with death assigned to other causes were similarly examined. Of these 13 cases were considered doubtful, and these roughly cancelled out the previous doubtful cases, and 137 were judged 'correct' in so far as death had not In most cases the cancers were diagnosed between 10-25 years after the onset of paraplegia, and a common feature was long-standing urinary infection. The histology was given as squamous cell cancer in 4 cases, transitional and squamous cell in 3, and transitional or papillary in the remainder. There is almost certainly an excess of bladder cancer in this population of paraplegics, but the excess cannot be measured in the absence of definition of the population by date, age, sex and number. By courtesy of the Office of Population Censuses and Surveys, the Division of Epidemiology has copies of all death certificates for men and women dying with bladder cancer since 1949, and all those which mentioned paraplegia or other relevant conditions were extracted; certificates for some of Melzak's cases -were recognized. Cases of interest were found at all ages, but cases in men and women dying under the age of 50 stood out more than those in older persons, the latter becoming inconspicuous among the increasing numbers of bladder cancer deaths in the middle-aged and elderly.
The number of times previous paraplegia is mentioned on certificates for men and women dying under the age of 50 is shown in Table 2 . The numbers are small, totalling 11 cases, including 3 of Melzak's, but at the youngest ages the number of certificates is also small. For deaths under the age of 40, 6 out of 406 certificates (1.5 %) mention Multiple sclerosis previous paraplegia, a proportion which suggests an association between the two conditions. Moreover, the total of 11 cases is almost certainly an understatement, for in some instances patients' paraplegia may not have been mentioned on their certificates, which was true of some of Melzak's cases. In other cases it was not clear from the wording of the cause of death whether the paraplegia which was mentioned had preceded the bladder cancer or was a secondary condition. Numerous other certificates showed that patients were crippled, invalids or disabled, but did not specify the nature of the disability. Most of the 11 certificates specify road accidents or injuries incurred during service in the armed forces as causes of the paraplegia, and most of the cases are in men. Some examples of further cases of men dying under the age of 50 where the possibility of chronic stasis or infection may arise are: age 36, metastases from a carcinoma of the bladder... probably associated with injuries received in an accident during service with the armed forces; age 46, cancer of the bladder contributed to by gunshot wounds in war service; age 47, carcinoma of bladder, urinary fistula, war wound of groin. Some other relevant cases where death occurred under the age of 50 are shown in Table 3 . The 4 spina bifida cases are of particular interest, and there was one further case in a man dying aged 69. There were numerous mentions of multiple sclerosis on the certificates of older patients, including 13 women and 24 men aged 50-69. Other conditions of interest mentioned in the certificates of older patients include poliomyelitis, spinal tuberculosis, and numerous cases of tabes dorsalis.
The data supplied on death certificates are scanty. Work is in progress to obtain additional information on all cases of the types mentioned, so as to explore further the possibility of excess mortality from bladder cancer among paraplegics and patients with other conditions likely to cause chronic urinary stasis and infection. Particular attention will be paid to histology, which is rarely specified on death certificates, since squamous cell cancers may be relatively common among such patients. In any site where nitrates, secondary amines and nitrate-reducing bacteria occur together, Nnitrosation can take place with the formation of nitrosamines (Hill & Hawksworth 1972) . In normal urine, nitrates are always present from dietary sources, as also are small amounts of secondary amines. If, in addition, an infection of the urinary tract with nitrate-reducing bacteria is present, conditions are theoretically right for the local production of nitrosamines within the bladder. This was confirmed by Hill & Hawksworth (1972) who demonstrated formation of the nitrosamine N-nitrosopiperidine in the urine of rats with experimentally-induced urinary infections who had been fed the parent amine piperidine. As a class nitrosamines and nitrosamides have been demonstrated to be powerful carcinogens in all animal species in which they have been tested and at least four have been shown to be selective bladder carcinogens (Druckrey et al. 1962 , Druckrey et al 1964 , Magee & Barnes 1967 , Hicks & Wakefield 1972 , Lijinsky & Taylor 1975 , Hirose et al. 1976 ).
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In man, as in animals, nitrate is always present in the urine from dietary sources, as also are small amounts of secondary amines (Asatoor & Simenhoff 1965) . The latter are normally formed by bacterial action on breakdown products of food in the intestine, reabsorbed into the blood stream, then excreted in the urine. The exact amount and chimal species of secondary amines present in the urine will be modified by diet and may be expected to vary in populations in different parts of the world. In patients with bacterial infection of the lower urinary tract it is possible that small amounts of nitrosamines may be produced which could initiate neoplastic or preneoplastic changes in the urothelium. If urinary nitrosamines play any part in the initiation of human bladder cancer, then nitrosamines should be detectable in infected human urine and, furthermore, bladder cancer incidence should be higher in populations subject to chronic urinary tract infections.
A preliminary study has been made of the nitrosamine content of urines from three groups of patients:
Group A: Patients under treatment for neoplastic bladder disease in the Middlesex Hospital. Urine samples were obtained with the collaboration of Mr E Milroy and his colleagues and Dr J Newman. Group B: Hemiplegic and paraplegic patients attending Stoke Mandeville Hospital. Bacteriological information and urine samples were supplied by Dr J Harris and his colleagues. Group C: Egyptian patients hospitalized for treatment of neoplastic bladder disease superimposed on bilharziasis of the urinary bladder. Method N-nitroso compounds can vary from simple, low molecular weight compounds to large complex molecules, and although many may be extracted from urine with the solvent dichloromethane some are unextractable and remain behind in the urine. At the present time no satisfactory method is available for the separation and characterization of individual unextractable urinary N-nitroso compounds, though they can be detected by a group test which is not yet proved to be completely specific (Preussman 1972) . Total amounts of volatile plus nonvolatile extractable nitrosamines in dichloromethane extracts of urines were determined by the Eisenbrand & Preussman method
